

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | COPI coating of Golgi vesicle (GO:0048205) | 7.05023253 |
| 2 | Golgi transport vesicle coating (GO:0048200) | 7.05023253 |
| 3 | pyrimidine nucleobase catabolic process (GO:0006208) | 6.15952452 |
| 4 | behavioral response to nicotine (GO:0035095) | 5.80031669 |
| 5 | nucleobase catabolic process (GO:0046113) | 5.16360064 |
| 6 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.08524496 |
| 7 | synaptic vesicle maturation (GO:0016188) | 4.91272396 |
| 8 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.63661041 |
| 9 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 4.63302123 |
| 10 | protein maturation by protein folding (GO:0022417) | 4.56841553 |
| 11 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.56142505 |
| 12 | insulin secretion (GO:0030073) | 4.46896268 |
| 13 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 4.45931601 |
| 14 | endocrine pancreas development (GO:0031018) | 4.45197252 |
| 15 | peptide hormone processing (GO:0016486) | 4.38977398 |
| 16 | synaptic vesicle exocytosis (GO:0016079) | 4.29097805 |
| 17 | detection of calcium ion (GO:0005513) | 4.28436935 |
| 18 | presynaptic membrane organization (GO:0097090) | 4.08957968 |
| 19 | regulation of synaptic vesicle transport (GO:1902803) | 3.95639762 |
| 20 | locomotory exploration behavior (GO:0035641) | 3.94048703 |
| 21 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 3.89190978 |
| 22 | vesicle coating (GO:0006901) | 3.88290260 |
| 23 | protein retention in ER lumen (GO:0006621) | 3.85222688 |
| 24 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.79834254 |
| 25 | positive regulation of insulin secretion (GO:0032024) | 3.79355315 |
| 26 | regulation of insulin secretion (GO:0050796) | 3.78358990 |
| 27 | transmission of nerve impulse (GO:0019226) | 3.73331397 |
| 28 | COPII vesicle coating (GO:0048208) | 3.72009162 |
| 29 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 3.67544608 |
| 30 | axonal fasciculation (GO:0007413) | 3.66160604 |
| 31 | auditory behavior (GO:0031223) | 3.65935975 |
| 32 | neuron cell-cell adhesion (GO:0007158) | 3.65770074 |
| 33 | cerebellar Purkinje cell layer development (GO:0021680) | 3.64650240 |
| 34 | establishment of mitochondrion localization (GO:0051654) | 3.63656818 |
| 35 | glutamate secretion (GO:0014047) | 3.59974174 |
| 36 | activation of protein kinase A activity (GO:0034199) | 3.55171503 |
| 37 | ER overload response (GO:0006983) | 3.54691763 |
| 38 | neurotransmitter secretion (GO:0007269) | 3.48727033 |
| 39 | neuron recognition (GO:0008038) | 3.47455178 |
| 40 | synapse assembly (GO:0007416) | 3.47404627 |
| 41 | regulation of peptide hormone secretion (GO:0090276) | 3.46600234 |
| 42 | negative regulation of catecholamine secretion (GO:0033604) | 3.44319146 |
| 43 | regulation of peptide secretion (GO:0002791) | 3.42264158 |
| 44 | peptide hormone secretion (GO:0030072) | 3.40280465 |
| 45 | signal peptide processing (GO:0006465) | 3.38043412 |
| 46 | regulation of calcium ion-dependent exocytosis (GO:0017158) | 3.35537148 |
| 47 | glandular epithelial cell differentiation (GO:0002067) | 3.29407286 |
| 48 | peptide secretion (GO:0002790) | 3.29401834 |
| 49 | vocalization behavior (GO:0071625) | 3.29083732 |
| 50 | type B pancreatic cell development (GO:0003323) | 3.28035619 |
| 51 | substrate-independent telencephalic tangential interneuron migration (GO:0021843) | 3.26816885 |
| 52 | substrate-independent telencephalic tangential migration (GO:0021826) | 3.26816885 |
| 53 | mechanosensory behavior (GO:0007638) | 3.25347232 |
| 54 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 3.22003544 |
| 55 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.21689721 |
| 56 | retinal ganglion cell axon guidance (GO:0031290) | 3.19014977 |
| 57 | nitric oxide mediated signal transduction (GO:0007263) | 3.17399371 |
| 58 | neurofilament cytoskeleton organization (GO:0060052) | 3.15446956 |
| 59 | positive regulation of peptide hormone secretion (GO:0090277) | 3.15255053 |
| 60 | neuronal action potential propagation (GO:0019227) | 3.11685180 |
| 61 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.10943669 |
| 62 | positive regulation of peptide secretion (GO:0002793) | 3.10497263 |
| 63 | negative regulation of norepinephrine secretion (GO:0010700) | 3.10356740 |
| 64 | nonmotile primary cilium assembly (GO:0035058) | 3.08598993 |
| 65 | positive regulation of exocytosis (GO:0045921) | 3.06736965 |
| 66 | exploration behavior (GO:0035640) | 3.06195618 |
| 67 | proline transport (GO:0015824) | 3.06056965 |
| 68 | intra-Golgi vesicle-mediated transport (GO:0006891) | 3.06023345 |
| 69 | regulation of hormone secretion (GO:0046883) | 3.03640078 |
| 70 | glandular epithelial cell development (GO:0002068) | 3.03249058 |
| 71 | signal release (GO:0023061) | 3.01797560 |
| 72 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 3.01626292 |
| 73 | mitochondrion transport along microtubule (GO:0047497) | 3.01626292 |
| 74 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.01469165 |
| 75 | regulation of vesicle fusion (GO:0031338) | 3.00375343 |
| 76 | positive regulation of nuclease activity (GO:0032075) | 3.00208555 |
| 77 | regulation of respiratory system process (GO:0044065) | 2.99899267 |
| 78 | regulation of glucocorticoid secretion (GO:2000849) | 2.99057970 |
| 79 | * cellular response to glucagon stimulus (GO:0071377) | 2.98478597 |
| 80 | regulation of glutamate receptor signaling pathway (GO:1900449) | 2.97576364 |
| 81 | response to pheromone (GO:0019236) | 2.97325213 |
| 82 | regulation of exocytosis (GO:0017157) | 2.95758603 |
| 83 | exocrine pancreas development (GO:0031017) | 2.95441354 |
| 84 | layer formation in cerebral cortex (GO:0021819) | 2.94448293 |
| 85 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 2.93624124 |
| 86 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.93064720 |
| 87 | synaptic transmission, cholinergic (GO:0007271) | 2.92594277 |
| 88 | synaptic transmission, glutamatergic (GO:0035249) | 2.92035150 |
| 89 | vesicle transport along microtubule (GO:0047496) | 2.90126194 |
| 90 | protein localization to cilium (GO:0061512) | 2.90085530 |
| 91 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.89557171 |
| 92 | protein targeting to Golgi (GO:0000042) | 2.89460502 |
| 93 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.89069946 |
| 94 | sequestering of metal ion (GO:0051238) | 2.88518495 |
| 95 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.88381438 |
| 96 | chemosensory behavior (GO:0007635) | 2.87413602 |
| 97 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 2.87092033 |
| 98 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.86737217 |
| 99 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 2.85702566 |
| 100 | postsynaptic membrane organization (GO:0001941) | 2.84687353 |
| 101 | neuromuscular synaptic transmission (GO:0007274) | 2.84580995 |
| 102 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.84579521 |
| 103 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.83400870 |
| 104 | regulation of cAMP-dependent protein kinase activity (GO:2000479) | 2.82897470 |
| 105 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.82582731 |
| 106 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.81949593 |
| 107 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339) | 2.81438823 |
| 108 | protein polyglutamylation (GO:0018095) | 2.80352584 |
| 109 | kidney morphogenesis (GO:0060993) | 2.80276470 |
| 110 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.79465845 |
| 111 | innervation (GO:0060384) | 2.78317860 |
| 112 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.77582714 |
| 113 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 2.77111190 |
| 114 | regulation of peptide transport (GO:0090087) | 2.76475278 |
| 115 | glycerophospholipid catabolic process (GO:0046475) | 2.76350212 |
| 116 | neurotransmitter transport (GO:0006836) | 2.76135741 |
| 117 | protein localization to Golgi apparatus (GO:0034067) | 2.75170544 |
| 118 | protein localization to synapse (GO:0035418) | 2.74302061 |
| 119 | positive regulation of synapse assembly (GO:0051965) | 2.73683156 |
| 120 | regulation of neurotransmitter uptake (GO:0051580) | 2.72969234 |
| 121 | glutamate receptor signaling pathway (GO:0007215) | 2.72787694 |
| 122 | organelle transport along microtubule (GO:0072384) | 2.72228635 |
| 123 | adult walking behavior (GO:0007628) | 2.71751116 |
| 124 | response to auditory stimulus (GO:0010996) | 2.71488386 |
| 125 | dendritic spine morphogenesis (GO:0060997) | 2.70845568 |
| 126 | regulation of nuclease activity (GO:0032069) | 2.69342897 |
| 127 | dendrite morphogenesis (GO:0048813) | 2.69124614 |
| 128 | inner ear receptor cell development (GO:0060119) | 2.68345741 |
| 129 | neuronal ion channel clustering (GO:0045161) | 2.66386189 |
| 130 | hormone secretion (GO:0046879) | 2.65639111 |
| 131 | neuromuscular process controlling posture (GO:0050884) | 2.65075805 |
| 132 | spinal cord development (GO:0021510) | 2.64790344 |
| 133 | positive regulation of membrane potential (GO:0045838) | 2.64350800 |
| 134 | neuron-neuron synaptic transmission (GO:0007270) | 2.64054326 |
| 135 | regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178) | 2.64037068 |
| 136 | synapse organization (GO:0050808) | 2.63518257 |
| 137 | cell communication by electrical coupling (GO:0010644) | 2.63413128 |
| 138 | cell migration in hindbrain (GO:0021535) | 2.63024631 |
| 139 | macroautophagy (GO:0016236) | 2.62954409 |
| 140 | positive regulation of vesicle fusion (GO:0031340) | 2.62420314 |
| 141 | toxin metabolic process (GO:0009404) | 2.61648474 |
| 142 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 2.60972744 |
| 143 | presynaptic membrane assembly (GO:0097105) | 2.59163140 |
| 144 | negative regulation of insulin secretion (GO:0046676) | 2.58361936 |
| 145 | regulation of beta-amyloid formation (GO:1902003) | 2.58131591 |
| 146 | regulation of synapse structural plasticity (GO:0051823) | 2.58055145 |
| 147 | endoplasmic reticulum unfolded protein response (GO:0030968) | 2.57732305 |
| 148 | gamma-aminobutyric acid transport (GO:0015812) | 2.57570799 |
| 149 | negative regulation of telomere maintenance (GO:0032205) | 2.56953154 |
| 150 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.56362341 |
| 151 | membrane depolarization during action potential (GO:0086010) | 2.55223957 |
| 152 | behavioral response to ethanol (GO:0048149) | 2.54975521 |
| 153 | regulation of catecholamine uptake involved in synaptic transmission (GO:0051940) | 2.53515454 |
| 154 | regulation of dopamine uptake involved in synaptic transmission (GO:0051584) | 2.53515454 |
| 155 | regulation of telomere maintenance (GO:0032204) | 2.52825421 |
| 156 | regulation of microtubule-based movement (GO:0060632) | 2.51541385 |
| 157 | cellular ketone body metabolic process (GO:0046950) | 2.51360801 |
| 158 | behavioral response to cocaine (GO:0048148) | 2.48394728 |
| 159 | startle response (GO:0001964) | 2.47302839 |
| 160 | regulation of respiratory gaseous exchange (GO:0043576) | 2.45935935 |
| 161 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.45907007 |
| 162 | olfactory bulb development (GO:0021772) | 2.44363298 |
| 163 | adult behavior (GO:0030534) | 2.44099731 |
| 164 | neuronal action potential (GO:0019228) | 2.39431738 |
| 165 | regulation of action potential (GO:0098900) | 2.38386656 |
| 166 | positive regulation of synapse maturation (GO:0090129) | 2.37580504 |
| 167 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:004316 | 2.36540508 |
| 168 | ganglion development (GO:0061548) | 2.34857165 |
| 169 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 2.34373845 |
| 170 | axon cargo transport (GO:0008088) | 2.33975952 |
| 171 | cell differentiation in spinal cord (GO:0021515) | 2.33531280 |
| 172 | spinal cord motor neuron differentiation (GO:0021522) | 2.33033777 |
| 173 | C4-dicarboxylate transport (GO:0015740) | 2.32291760 |
| 174 | multicellular organismal signaling (GO:0035637) | 2.31264077 |
| 175 | cell proliferation in forebrain (GO:0021846) | 2.30244702 |
| 176 | membrane hyperpolarization (GO:0060081) | 2.29773399 |
| 177 | protein complex biogenesis (GO:0070271) | 2.29272999 |
| 178 | reflex (GO:0060004) | 2.29232833 |
| 179 | anterograde axon cargo transport (GO:0008089) | 2.28697064 |
| 180 | intraciliary transport (GO:0042073) | 2.28556116 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.05213647 |
| 2 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.50923737 |
| 3 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.27301033 |
| 4 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 2.99837168 |
| 5 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.61860838 |
| 6 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.48675634 |
| 7 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.47205713 |
| 8 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.43041959 |
| 9 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.39417910 |
| 10 | * SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.31851670 |
| 11 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.27384095 |
| 12 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 2.20493623 |
| 13 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.16438749 |
| 14 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.15410100 |
| 15 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.14991999 |
| 16 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.14955052 |
| 17 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.14296784 |
| 18 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.12728353 |
| 19 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.12253682 |
| 20 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.11402045 |
| 21 | * JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.06800741 |
| 22 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.00907437 |
| 23 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.98071641 |
| 24 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.94068501 |
| 25 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.90593344 |
| 26 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.90304324 |
| 27 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.89803821 |
| 28 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.87941662 |
| 29 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.86894058 |
| 30 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.84102115 |
| 31 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.81605434 |
| 32 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.81605434 |
| 33 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.70284083 |
| 34 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.68284605 |
| 35 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.64043153 |
| 36 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.61582362 |
| 37 | FUS_26573619_Chip-Seq_HEK293_Human | 1.60984724 |
| 38 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.50876734 |
| 39 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.50611383 |
| 40 | STAT3_23295773_ChIP-Seq_U87_Human | 1.50281891 |
| 41 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.48889399 |
| 42 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.48501880 |
| 43 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.44312604 |
| 44 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.42040220 |
| 45 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.41139400 |
| 46 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.39895019 |
| 47 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.38116457 |
| 48 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.38095153 |
| 49 | * EWS_26573619_Chip-Seq_HEK293_Human | 1.37074528 |
| 50 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.35409953 |
| 51 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.35409953 |
| 52 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.32393087 |
| 53 | * RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.32171984 |
| 54 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.31963507 |
| 55 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.30159773 |
| 56 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.29657229 |
| 57 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.29415274 |
| 58 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.29383920 |
| 59 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.24510482 |
| 60 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.24494252 |
| 61 | P300_19829295_ChIP-Seq_ESCs_Human | 1.24183488 |
| 62 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.23585288 |
| 63 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.22138448 |
| 64 | * OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.20861989 |
| 65 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.20265317 |
| 66 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.20107279 |
| 67 | * PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.20040268 |
| 68 | AR_25329375_ChIP-Seq_VCAP_Human | 1.19735293 |
| 69 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.19118435 |
| 70 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 1.19001255 |
| 71 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.18731005 |
| 72 | AR_19668381_ChIP-Seq_PC3_Human | 1.18675185 |
| 73 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.18633963 |
| 74 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.18090709 |
| 75 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.17824039 |
| 76 | * REST_19997604_ChIP-ChIP_NEURONS_Mouse | 1.17744245 |
| 77 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.17519491 |
| 78 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.17207762 |
| 79 | GATA1_22025678_ChIP-Seq_K562_Human | 1.16618243 |
| 80 | TCF4_23295773_ChIP-Seq_U87_Human | 1.16275937 |
| 81 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.16073534 |
| 82 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.15827715 |
| 83 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.15827715 |
| 84 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.14498529 |
| 85 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 1.14427870 |
| 86 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.12538871 |
| 87 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.12116977 |
| 88 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.11015240 |
| 89 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.10994587 |
| 90 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.09786265 |
| 91 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.09641709 |
| 92 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.09267690 |
| 93 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.08933829 |
| 94 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.07003712 |
| 95 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.06043687 |
| 96 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.05893659 |
| 97 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.04857919 |
| 98 | * TP53_22573176_ChIP-Seq_HFKS_Human | 1.04817518 |
| 99 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.03973840 |
| 100 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.03944536 |
| 101 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.03663858 |
| 102 | VDR_22108803_ChIP-Seq_LS180_Human | 1.03549672 |
| 103 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.03284915 |
| 104 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.00251398 |
| 105 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.99673282 |
| 106 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.99344220 |
| 107 | * FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.96909717 |
| 108 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.96767248 |
| 109 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.96695715 |
| 110 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.96115930 |
| 111 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.95571978 |
| 112 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.95375960 |
| 113 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.94618150 |
| 114 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.94170151 |
| 115 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 0.92671361 |
| 116 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.92369501 |
| 117 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.92362803 |
| 118 | SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 0.91690292 |
| 119 | JUN_21703547_ChIP-Seq_K562_Human | 0.91037729 |
| 120 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.90813728 |
| 121 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.89959212 |
| 122 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.89897607 |
| 123 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.89362830 |
| 124 | * SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.89075445 |
| 125 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.88391168 |
| 126 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.88324974 |
| 127 | * TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.88253881 |
| 128 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.87981106 |
| 129 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.87883298 |
| 130 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.86497728 |
| 131 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.85281794 |
| 132 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.84142295 |
| 133 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.83847597 |
| 134 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.81561862 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0009780_abnormal_chondrocyte_physiolo | 4.19218561 |
| 2 | MP0002909_abnormal_adrenal_gland | 3.78315502 |
| 3 | MP0003283_abnormal_digestive_organ | 3.47514396 |
| 4 | MP0002877_abnormal_melanocyte_morpholog | 3.44446182 |
| 5 | MP0004859_abnormal_synaptic_plasticity | 3.32853136 |
| 6 | MP0004043_abnormal_pH_regulation | 3.28073357 |
| 7 | MP0000013_abnormal_adipose_tissue | 3.25105805 |
| 8 | MP0004270_analgesia | 3.13106502 |
| 9 | MP0010386_abnormal_urinary_bladder | 2.89538644 |
| 10 | MP0002693_abnormal_pancreas_physiology | 2.83999847 |
| 11 | MP0002837_dystrophic_cardiac_calcinosis | 2.72405379 |
| 12 | MP0003635_abnormal_synaptic_transmissio | 2.64128081 |
| 13 | MP0003183_abnormal_peptide_metabolism | 2.50771036 |
| 14 | MP0001944_abnormal_pancreas_morphology | 2.50370938 |
| 15 | MP0005645_abnormal_hypothalamus_physiol | 2.48118617 |
| 16 | MP0005646_abnormal_pituitary_gland | 2.38211212 |
| 17 | MP0005379_endocrine/exocrine_gland_phen | 2.35512883 |
| 18 | MP0008877_abnormal_DNA_methylation | 2.30729340 |
| 19 | MP0003122_maternal_imprinting | 2.29684394 |
| 20 | MP0003195_calcinosis | 2.24136599 |
| 21 | MP0000678_abnormal_parathyroid_gland | 2.22687271 |
| 22 | MP0002734_abnormal_mechanical_nocicepti | 2.15910862 |
| 23 | MP0002063_abnormal_learning/memory/cond | 2.05510369 |
| 24 | MP0003880_abnormal_central_pattern | 1.90907530 |
| 25 | MP0003123_paternal_imprinting | 1.87705502 |
| 26 | MP0002572_abnormal_emotion/affect_behav | 1.87328379 |
| 27 | MP0002102_abnormal_ear_morphology | 1.87111367 |
| 28 | MP0009745_abnormal_behavioral_response | 1.87085575 |
| 29 | MP0002733_abnormal_thermal_nociception | 1.85417052 |
| 30 | MP0006292_abnormal_olfactory_placode | 1.83974542 |
| 31 | MP0006072_abnormal_retinal_apoptosis | 1.81199929 |
| 32 | MP0002638_abnormal_pupillary_reflex | 1.79475384 |
| 33 | MP0002064_seizures | 1.78508693 |
| 34 | MP0004142_abnormal_muscle_tone | 1.76621259 |
| 35 | MP0002078_abnormal_glucose_homeostasis | 1.71683719 |
| 36 | MP0003787_abnormal_imprinting | 1.62760360 |
| 37 | MP0001970_abnormal_pain_threshold | 1.59942553 |
| 38 | MP0002272_abnormal_nervous_system | 1.59730922 |
| 39 | MP0006276_abnormal_autonomic_nervous | 1.58581097 |
| 40 | MP0005423_abnormal_somatic_nervous | 1.58075111 |
| 41 | MP0002653_abnormal_ependyma_morphology | 1.56809488 |
| 42 | MP0005551_abnormal_eye_electrophysiolog | 1.54414108 |
| 43 | MP0002735_abnormal_chemical_nociception | 1.51702901 |
| 44 | MP0004133_heterotaxia | 1.49075577 |
| 45 | MP0000003_abnormal_adipose_tissue | 1.48075778 |
| 46 | MP0005220_abnormal_exocrine_pancreas | 1.47354751 |
| 47 | MP0009046_muscle_twitch | 1.45313671 |
| 48 | MP0001501_abnormal_sleep_pattern | 1.43802893 |
| 49 | MP0003879_abnormal_hair_cell | 1.42652209 |
| 50 | MP0008961_abnormal_basal_metabolism | 1.42371642 |
| 51 | MP0002557_abnormal_social/conspecific_i | 1.40955657 |
| 52 | MP0005499_abnormal_olfactory_system | 1.40555887 |
| 53 | MP0005394_taste/olfaction_phenotype | 1.40555887 |
| 54 | MP0003172_abnormal_lysosome_physiology | 1.39084450 |
| 55 | MP0001502_abnormal_circadian_rhythm | 1.38348579 |
| 56 | MP0001485_abnormal_pinna_reflex | 1.38019834 |
| 57 | MP0002876_abnormal_thyroid_physiology | 1.36426254 |
| 58 | MP0001968_abnormal_touch/_nociception | 1.34634967 |
| 59 | MP0002184_abnormal_innervation | 1.33015352 |
| 60 | MP0004858_abnormal_nervous_system | 1.30905763 |
| 61 | MP0002822_catalepsy | 1.29808443 |
| 62 | MP0001986_abnormal_taste_sensitivity | 1.29323987 |
| 63 | MP0000955_abnormal_spinal_cord | 1.28374975 |
| 64 | MP0004811_abnormal_neuron_physiology | 1.28179691 |
| 65 | MP0001905_abnormal_dopamine_level | 1.28165746 |
| 66 | MP0002234_abnormal_pharynx_morphology | 1.27770807 |
| 67 | MP0000631_abnormal_neuroendocrine_gland | 1.25128972 |
| 68 | MP0001486_abnormal_startle_reflex | 1.23300928 |
| 69 | MP0008789_abnormal_olfactory_epithelium | 1.23051648 |
| 70 | MP0004742_abnormal_vestibular_system | 1.22508961 |
| 71 | MP0003890_abnormal_embryonic-extraembry | 1.19760232 |
| 72 | MP0003329_amyloid_beta_deposits | 1.19677683 |
| 73 | MP0003011_delayed_dark_adaptation | 1.19277899 |
| 74 | MP0005535_abnormal_body_temperature | 1.18348772 |
| 75 | MP0002752_abnormal_somatic_nervous | 1.18127963 |
| 76 | MP0000462_abnormal_digestive_system | 1.17566468 |
| 77 | MP0003953_abnormal_hormone_level | 1.16192704 |
| 78 | MP0004924_abnormal_behavior | 1.10175936 |
| 79 | MP0005386_behavior/neurological_phenoty | 1.10175936 |
| 80 | MP0001440_abnormal_grooming_behavior | 1.09811627 |
| 81 | MP0002067_abnormal_sensory_capabilities | 1.09544906 |
| 82 | MP0002896_abnormal_bone_mineralization | 1.09497374 |
| 83 | MP0001984_abnormal_olfaction | 1.08560360 |
| 84 | MP0002938_white_spotting | 1.08005067 |
| 85 | MP0002152_abnormal_brain_morphology | 1.07226960 |
| 86 | MP0008569_lethality_at_weaning | 1.04774388 |
| 87 | MP0002163_abnormal_gland_morphology | 1.02120745 |
| 88 | MP0004885_abnormal_endolymph | 1.00252809 |
| 89 | MP0002069_abnormal_eating/drinking_beha | 0.97617932 |
| 90 | MP0008872_abnormal_physiological_respon | 0.96715140 |
| 91 | MP0000049_abnormal_middle_ear | 0.96504755 |
| 92 | MP0000026_abnormal_inner_ear | 0.96330654 |
| 93 | MP0001765_abnormal_ion_homeostasis | 0.95540118 |
| 94 | MP0003861_abnormal_nervous_system | 0.95218074 |
| 95 | MP0002066_abnormal_motor_capabilities/c | 0.95087290 |
| 96 | MP0002882_abnormal_neuron_morphology | 0.93835039 |
| 97 | MP0005187_abnormal_penis_morphology | 0.93824909 |
| 98 | MP0002928_abnormal_bile_duct | 0.93103602 |
| 99 | MP0000778_abnormal_nervous_system | 0.92096638 |
| 100 | MP0001963_abnormal_hearing_physiology | 0.91974396 |
| 101 | MP0000566_synostosis | 0.91263354 |
| 102 | MP0005195_abnormal_posterior_eye | 0.90776222 |
| 103 | MP0000613_abnormal_salivary_gland | 0.86839943 |
| 104 | MP0003119_abnormal_digestive_system | 0.86808093 |
| 105 | MP0000569_abnormal_digit_pigmentation | 0.86664681 |
| 106 | MP0003633_abnormal_nervous_system | 0.86636499 |
| 107 | MP0001299_abnormal_eye_distance/ | 0.86122122 |
| 108 | MP0005448_abnormal_energy_balance | 0.85934774 |
| 109 | MP0004264_abnormal_extraembryonic_tissu | 0.84842719 |
| 110 | MP0003938_abnormal_ear_development | 0.80015020 |
| 111 | MP0001529_abnormal_vocalization | 0.77880168 |
| 112 | MP0002229_neurodegeneration | 0.77809353 |
| 113 | MP0002160_abnormal_reproductive_system | 0.77111976 |
| 114 | MP0000681_abnormal_thyroid_gland | 0.76323723 |
| 115 | MP0003634_abnormal_glial_cell | 0.76131990 |
| 116 | MP0002736_abnormal_nociception_after | 0.74797756 |
| 117 | MP0000538_abnormal_urinary_bladder | 0.74306237 |
| 118 | MP0001664_abnormal_digestion | 0.73708278 |
| 119 | MP0003959_abnormal_lean_body | 0.73062545 |
| 120 | MP0003878_abnormal_ear_physiology | 0.73051161 |
| 121 | MP0005377_hearing/vestibular/ear_phenot | 0.73051161 |
| 122 | MP0003868_abnormal_feces_composition | 0.71492203 |
| 123 | MP0005310_abnormal_salivary_gland | 0.71461150 |
| 124 | MP0003937_abnormal_limbs/digits/tail_de | 0.70598190 |
| 125 | MP0001270_distended_abdomen | 0.70431054 |
| 126 | MP0000230_abnormal_systemic_arterial | 0.69794194 |
| 127 | MP0004085_abnormal_heartbeat | 0.69563404 |
| 128 | MP0001188_hyperpigmentation | 0.68992662 |
| 129 | MP0003121_genomic_imprinting | 0.68259434 |
| 130 | MP0002751_abnormal_autonomic_nervous | 0.67951870 |
| 131 | MP0005253_abnormal_eye_physiology | 0.67516782 |
| 132 | MP0004145_abnormal_muscle_electrophysio | 0.66935164 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 6.52297835 |
| 2 | Hyperinsulinemic hypoglycemia (HP:0000825) | 5.71332903 |
| 3 | Hypoglycemic seizures (HP:0002173) | 5.29221243 |
| 4 | Symptomatic seizures (HP:0011145) | 5.12624727 |
| 5 | Visual hallucinations (HP:0002367) | 4.86084213 |
| 6 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 4.42318723 |
| 7 | Agitation (HP:0000713) | 4.00574096 |
| 8 | Hypoglycemic coma (HP:0001325) | 3.92510238 |
| 9 | Hyperglycemia (HP:0003074) | 3.68945356 |
| 10 | Pheochromocytoma (HP:0002666) | 3.62232198 |
| 11 | Insulin-resistant diabetes mellitus (HP:0000831) | 3.61456145 |
| 12 | Papilledema (HP:0001085) | 3.58460737 |
| 13 | Decreased circulating renin level (HP:0003351) | 3.55769972 |
| 14 | EEG with generalized epileptiform discharges (HP:0011198) | 3.31408945 |
| 15 | Hypsarrhythmia (HP:0002521) | 3.27979666 |
| 16 | Ketoacidosis (HP:0001993) | 3.27719580 |
| 17 | Focal motor seizures (HP:0011153) | 3.24145843 |
| 18 | Pancreatic fibrosis (HP:0100732) | 3.23719807 |
| 19 | Epileptiform EEG discharges (HP:0011182) | 3.22237004 |
| 20 | Pancreatic cysts (HP:0001737) | 3.17842271 |
| 21 | Neuroendocrine neoplasm (HP:0100634) | 3.16739704 |
| 22 | Abnormality of endocrine pancreas physiology (HP:0012093) | 3.14604900 |
| 23 | Abnormality of the pancreatic islet cells (HP:0006476) | 3.14604900 |
| 24 | Nephronophthisis (HP:0000090) | 3.04363611 |
| 25 | Polyphagia (HP:0002591) | 3.03541325 |
| 26 | True hermaphroditism (HP:0010459) | 3.00348520 |
| 27 | Abnormality of midbrain morphology (HP:0002418) | 2.92393364 |
| 28 | Molar tooth sign on MRI (HP:0002419) | 2.92393364 |
| 29 | Epileptic encephalopathy (HP:0200134) | 2.90983232 |
| 30 | Medial flaring of the eyebrow (HP:0010747) | 2.87891713 |
| 31 | Lissencephaly (HP:0001339) | 2.84203540 |
| 32 | Large for gestational age (HP:0001520) | 2.83066569 |
| 33 | Hyperparathyroidism (HP:0000843) | 2.82468324 |
| 34 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.82182983 |
| 35 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.79528929 |
| 36 | Mucopolysacchariduria (HP:0008155) | 2.79528929 |
| 37 | Abnormal pancreas size (HP:0012094) | 2.73804280 |
| 38 | Hemiparesis (HP:0001269) | 2.73282402 |
| 39 | Abnormality of the labia minora (HP:0012880) | 2.73103982 |
| 40 | Atonic seizures (HP:0010819) | 2.69067098 |
| 41 | Hypokalemia (HP:0002900) | 2.69030131 |
| 42 | Hypercortisolism (HP:0001578) | 2.67365030 |
| 43 | Broad-based gait (HP:0002136) | 2.64039919 |
| 44 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.58876897 |
| 45 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.58876897 |
| 46 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.58876897 |
| 47 | Absence seizures (HP:0002121) | 2.58275159 |
| 48 | Late onset (HP:0003584) | 2.58244098 |
| 49 | Focal seizures (HP:0007359) | 2.57409298 |
| 50 | Retinal dysplasia (HP:0007973) | 2.56363973 |
| 51 | Congenital primary aphakia (HP:0007707) | 2.55831808 |
| 52 | Menstrual irregularities (HP:0000858) | 2.55443544 |
| 53 | Supranuclear gaze palsy (HP:0000605) | 2.51911370 |
| 54 | Osteomalacia (HP:0002749) | 2.49877373 |
| 55 | Dysostosis multiplex (HP:0000943) | 2.48778189 |
| 56 | Anxiety (HP:0000739) | 2.46944397 |
| 57 | Pachygyria (HP:0001302) | 2.46094965 |
| 58 | Abnormality of the renal medulla (HP:0100957) | 2.45468002 |
| 59 | Depression (HP:0000716) | 2.44440322 |
| 60 | Failure to thrive in infancy (HP:0001531) | 2.43502629 |
| 61 | Limb dystonia (HP:0002451) | 2.43253072 |
| 62 | Nephrogenic diabetes insipidus (HP:0009806) | 2.40730167 |
| 63 | Hypothermia (HP:0002045) | 2.37731627 |
| 64 | Generalized tonic-clonic seizures (HP:0002069) | 2.36948630 |
| 65 | Congenital stationary night blindness (HP:0007642) | 2.35949288 |
| 66 | Genital tract atresia (HP:0001827) | 2.31050267 |
| 67 | Amblyopia (HP:0000646) | 2.30927536 |
| 68 | Abnormality of renin-angiotensin system (HP:0000847) | 2.30123534 |
| 69 | Chronic hepatic failure (HP:0100626) | 2.30069828 |
| 70 | Pendular nystagmus (HP:0012043) | 2.30069025 |
| 71 | Vaginal atresia (HP:0000148) | 2.29221364 |
| 72 | Ankle clonus (HP:0011448) | 2.28967337 |
| 73 | Myokymia (HP:0002411) | 2.28595217 |
| 74 | Retinal atrophy (HP:0001105) | 2.23744562 |
| 75 | Macroorchidism (HP:0000053) | 2.22126215 |
| 76 | Poor suck (HP:0002033) | 2.21929294 |
| 77 | Dialeptic seizures (HP:0011146) | 2.20118440 |
| 78 | Sclerocornea (HP:0000647) | 2.19773650 |
| 79 | Restlessness (HP:0000711) | 2.19191919 |
| 80 | Cystic liver disease (HP:0006706) | 2.18996858 |
| 81 | Intestinal atresia (HP:0011100) | 2.14439763 |
| 82 | Oligodactyly (hands) (HP:0001180) | 2.13028633 |
| 83 | Specific learning disability (HP:0001328) | 2.11705986 |
| 84 | Papillary thyroid carcinoma (HP:0002895) | 2.11562171 |
| 85 | Abnormality of potassium homeostasis (HP:0011042) | 2.08795769 |
| 86 | Adrenal overactivity (HP:0002717) | 2.08327130 |
| 87 | Dysautonomia (HP:0002459) | 2.06634714 |
| 88 | Cortical visual impairment (HP:0100704) | 2.06437344 |
| 89 | Hyperactive renin-angiotensin system (HP:0000841) | 2.06103092 |
| 90 | Acute necrotizing encephalopathy (HP:0006965) | 2.05560060 |
| 91 | Spastic tetraplegia (HP:0002510) | 2.05090738 |
| 92 | Generalized aminoaciduria (HP:0002909) | 2.04388492 |
| 93 | Amelogenesis imperfecta (HP:0000705) | 2.02627101 |
| 94 | Drooling (HP:0002307) | 2.01525049 |
| 95 | Excessive salivation (HP:0003781) | 2.01525049 |
| 96 | Truncal ataxia (HP:0002078) | 2.01191360 |
| 97 | Optic nerve hypoplasia (HP:0000609) | 1.99615046 |
| 98 | Poor coordination (HP:0002370) | 1.97333197 |
| 99 | Absent speech (HP:0001344) | 1.97192943 |
| 100 | Muscular hypotonia of the trunk (HP:0008936) | 1.97035640 |
| 101 | Congenital glaucoma (HP:0001087) | 1.96928307 |
| 102 | Inability to walk (HP:0002540) | 1.96565973 |
| 103 | Neurofibrillary tangles (HP:0002185) | 1.95904708 |
| 104 | Progressive cerebellar ataxia (HP:0002073) | 1.95756582 |
| 105 | Hyperkalemia (HP:0002153) | 1.95340292 |
| 106 | Genetic anticipation (HP:0003743) | 1.93937133 |
| 107 | Prominent metopic ridge (HP:0005487) | 1.93262277 |
| 108 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 1.92708210 |
| 109 | Abnormal eating behavior (HP:0100738) | 1.90462566 |
| 110 | Postural tremor (HP:0002174) | 1.90258997 |
| 111 | Cerebral inclusion bodies (HP:0100314) | 1.90214979 |
| 112 | Anencephaly (HP:0002323) | 1.90181980 |
| 113 | Hyperglycinemia (HP:0002154) | 1.90054196 |
| 114 | Gait imbalance (HP:0002141) | 1.89919162 |
| 115 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.89270368 |
| 116 | Type II lissencephaly (HP:0007260) | 1.89059205 |
| 117 | Hypoplasia of the brainstem (HP:0002365) | 1.88759918 |
| 118 | Aplasia/Hypoplasia of the brainstem (HP:0007362) | 1.88759918 |
| 119 | Neoplasm of the heart (HP:0100544) | 1.88512509 |
| 120 | Narrow forehead (HP:0000341) | 1.88170656 |
| 121 | Blue irides (HP:0000635) | 1.87758129 |
| 122 | Occipital encephalocele (HP:0002085) | 1.86748749 |
| 123 | Abnormality of the renal cortex (HP:0011035) | 1.86553047 |
| 124 | Resting tremor (HP:0002322) | 1.85055932 |
| 125 | Progressive macrocephaly (HP:0004481) | 1.83104011 |
| 126 | Growth hormone excess (HP:0000845) | 1.82536190 |
| 127 | Anophthalmia (HP:0000528) | 1.81288975 |
| 128 | Hyperventilation (HP:0002883) | 1.80984783 |
| 129 | Abolished electroretinogram (ERG) (HP:0000550) | 1.79751299 |
| 130 | Testicular neoplasm (HP:0010788) | 1.79312641 |
| 131 | Acute encephalopathy (HP:0006846) | 1.78756667 |
| 132 | Gaze-evoked nystagmus (HP:0000640) | 1.77639552 |
| 133 | Increased circulating renin level (HP:0000848) | 1.75495439 |
| 134 | Hepatoblastoma (HP:0002884) | 1.75332382 |
| 135 | Insulin resistance (HP:0000855) | 1.75278760 |
| 136 | Methylmalonic acidemia (HP:0002912) | 1.74940331 |
| 137 | Hyperphosphatemia (HP:0002905) | 1.74909814 |
| 138 | Oligomenorrhea (HP:0000876) | 1.74829894 |
| 139 | Unilateral renal agenesis (HP:0000122) | 1.74648592 |
| 140 | Protruding tongue (HP:0010808) | 1.74641991 |
| 141 | Psychosis (HP:0000709) | 1.74140480 |
| 142 | Akinesia (HP:0002304) | 1.72674515 |
| 143 | Cortical dysplasia (HP:0002539) | 1.72444644 |
| 144 | Clonus (HP:0002169) | 1.72230878 |
| 145 | Chronic bronchitis (HP:0004469) | 1.71530951 |
| 146 | Severe muscular hypotonia (HP:0006829) | 1.71346295 |
| 147 | Megalencephaly (HP:0001355) | 1.71268829 |
| 148 | Cerebellar dysplasia (HP:0007033) | 1.71151903 |
| 149 | Esotropia (HP:0000565) | 1.71077304 |
| 150 | Attenuation of retinal blood vessels (HP:0007843) | 1.70783057 |
| 151 | Postaxial hand polydactyly (HP:0001162) | 1.70736325 |
| 152 | Neoplasm of the peripheral nervous system (HP:0100007) | 1.70726125 |
| 153 | Bony spicule pigmentary retinopathy (HP:0007737) | 1.70539015 |
| 154 | Hypotension (HP:0002615) | 1.70184498 |
| 155 | Abnormality of the corticospinal tract (HP:0002492) | 1.70173546 |
| 156 | Neoplasm of the adrenal gland (HP:0100631) | 1.70093761 |
| 157 | Abnormal drinking behavior (HP:0030082) | 1.69850338 |
| 158 | Polydipsia (HP:0001959) | 1.69850338 |
| 159 | Mitochondrial inheritance (HP:0001427) | 1.69088363 |
| 160 | Febrile seizures (HP:0002373) | 1.69077307 |
| 161 | Progressive neurologic deterioration (HP:0002344) | 1.69052276 |
| 162 | Impaired smooth pursuit (HP:0007772) | 1.68479472 |
| 163 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.68461591 |
| 164 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 1.68328107 |
| 165 | Neoplasm of the adrenal cortex (HP:0100641) | 1.67597375 |
| 166 | Male pseudohermaphroditism (HP:0000037) | 1.67167760 |
| 167 | Exotropia (HP:0000577) | 1.66843154 |
| 168 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.66521233 |
| 169 | Abnormality of the metopic suture (HP:0005556) | 1.64701275 |
| 170 | Polymicrogyria (HP:0002126) | 1.64272071 |
| 171 | Partial agenesis of the corpus callosum (HP:0001338) | 1.62599197 |
| 172 | Hypomagnesemia (HP:0002917) | 1.61487638 |
| 173 | Sleep apnea (HP:0010535) | 1.61439047 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | INSRR | 4.37854611 |
| 2 | MARK1 | 3.82067380 |
| 3 | NTRK3 | 3.81280820 |
| 4 | PASK | 3.54241437 |
| 5 | MAP3K2 | 2.88843345 |
| 6 | MAPK15 | 2.75665512 |
| 7 | PRKD3 | 2.60895045 |
| 8 | NTRK1 | 2.59331261 |
| 9 | MAP3K9 | 2.43076221 |
| 10 | HIPK2 | 2.32571228 |
| 11 | MAP3K4 | 2.27438513 |
| 12 | FRK | 2.18587232 |
| 13 | MAP2K7 | 2.08133595 |
| 14 | SCYL2 | 1.97919877 |
| 15 | WNK3 | 1.96561012 |
| 16 | UHMK1 | 1.90092572 |
| 17 | PINK1 | 1.84552087 |
| 18 | MINK1 | 1.81872092 |
| 19 | MAP4K2 | 1.81811742 |
| 20 | TAOK3 | 1.73115773 |
| 21 | CAMKK2 | 1.72541193 |
| 22 | ADRBK2 | 1.68465502 |
| 23 | WNK4 | 1.46914375 |
| 24 | NTRK2 | 1.41309785 |
| 25 | GRK1 | 1.39206315 |
| 26 | CAMKK1 | 1.37854751 |
| 27 | MAP3K1 | 1.37807889 |
| 28 | PAK3 | 1.35346321 |
| 29 | CDC42BPA | 1.33534802 |
| 30 | CSNK1G3 | 1.32536051 |
| 31 | KSR2 | 1.32367605 |
| 32 | TRIM28 | 1.29997294 |
| 33 | CASK | 1.28994660 |
| 34 | DAPK2 | 1.27982614 |
| 35 | AKT3 | 1.25930302 |
| 36 | MAP2K4 | 1.24404956 |
| 37 | GRK5 | 1.21970293 |
| 38 | CDK5 | 1.21968943 |
| 39 | PAK6 | 1.21547496 |
| 40 | CSNK1G1 | 1.16277684 |
| 41 | CSNK1A1L | 1.15617013 |
| 42 | ZAK | 1.15162604 |
| 43 | PRKCH | 1.14691499 |
| 44 | RET | 1.12416598 |
| 45 | MAP3K12 | 1.09880393 |
| 46 | ERBB3 | 1.07011918 |
| 47 | MAPK13 | 1.06191348 |
| 48 | OXSR1 | 0.99859400 |
| 49 | PRKCG | 0.98126453 |
| 50 | MKNK2 | 0.96167938 |
| 51 | FGFR2 | 0.95704833 |
| 52 | PRKCE | 0.94677325 |
| 53 | CDK19 | 0.94068557 |
| 54 | NUAK1 | 0.91931608 |
| 55 | STK39 | 0.91333874 |
| 56 | PLK2 | 0.88249014 |
| 57 | PHKG1 | 0.85681933 |
| 58 | PHKG2 | 0.85681933 |
| 59 | DYRK1A | 0.84758356 |
| 60 | PDGFRA | 0.83819971 |
| 61 | EPHB2 | 0.83201671 |
| 62 | RPS6KA2 | 0.81968149 |
| 63 | FLT3 | 0.78195147 |
| 64 | TYRO3 | 0.78045339 |
| 65 | SGK223 | 0.77655787 |
| 66 | SGK494 | 0.77655787 |
| 67 | EPHA4 | 0.77198033 |
| 68 | DAPK1 | 0.76336495 |
| 69 | DYRK3 | 0.76082566 |
| 70 | CSNK1G2 | 0.75851479 |
| 71 | FER | 0.74876141 |
| 72 | KSR1 | 0.73508877 |
| 73 | PTK2 | 0.71023181 |
| 74 | DYRK2 | 0.70844585 |
| 75 | EPHA3 | 0.70781069 |
| 76 | TLK1 | 0.70670528 |
| 77 | PKN1 | 0.70360289 |
| 78 | CAMK1D | 0.68761092 |
| 79 | ALK | 0.68334879 |
| 80 | SIK2 | 0.67261216 |
| 81 | STK38L | 0.66888812 |
| 82 | CAMK2A | 0.66473032 |
| 83 | PNCK | 0.66356765 |
| 84 | SGK2 | 0.66313543 |
| 85 | IRAK1 | 0.65590395 |
| 86 | MARK2 | 0.63447022 |
| 87 | BRAF | 0.63407899 |
| 88 | CAMK2D | 0.61438397 |
| 89 | LIMK1 | 0.59934200 |
| 90 | ARAF | 0.58284343 |
| 91 | BMPR2 | 0.57203861 |
| 92 | CSNK1E | 0.56476308 |
| 93 | TNIK | 0.55794494 |
| 94 | BCKDK | 0.54645126 |
| 95 | PRPF4B | 0.53802701 |
| 96 | CAMK2B | 0.52795930 |
| 97 | BRSK1 | 0.52331247 |
| 98 | PRKAA1 | 0.51879182 |
| 99 | BMPR1B | 0.51730873 |
| 100 | NME1 | 0.51276026 |
| 101 | CSNK1D | 0.50717370 |
| 102 | STK16 | 0.50526372 |
| 103 | CDK14 | 0.50484563 |
| 104 | BCR | 0.49000407 |
| 105 | IRAK2 | 0.48943644 |
| 106 | SGK1 | 0.48561076 |
| 107 | CAMK1G | 0.48310986 |
| 108 | VRK1 | 0.46827092 |
| 109 | RPS6KB1 | 0.46129729 |
| 110 | ERN1 | 0.45452775 |
| 111 | SGK3 | 0.44041684 |
| 112 | PRKCI | 0.43108839 |
| 113 | MAP2K1 | 0.42997907 |
| 114 | CAMK1 | 0.42338116 |
| 115 | CAMK4 | 0.42174804 |
| 116 | DYRK1B | 0.41217935 |
| 117 | WNK1 | 0.40873921 |
| 118 | PRKCZ | 0.40451603 |
| 119 | IRAK3 | 0.40068775 |
| 120 | PRKG1 | 0.40050538 |
| 121 | ADRBK1 | 0.39179769 |
| 122 | PLK3 | 0.37267167 |
| 123 | RPS6KA3 | 0.37101985 |
| 124 | CDK18 | 0.36294649 |
| 125 | PRKACG | 0.36184746 |
| 126 | CSNK1A1 | 0.36081916 |
| 127 | FES | 0.35998147 |
| 128 | CDK11A | 0.35855819 |
| 129 | STK11 | 0.35340358 |
| 130 | CDK15 | 0.34057998 |
| 131 | ACVR1B | 0.33909051 |
| 132 | TESK1 | 0.32351902 |
| 133 | PRKACA | 0.32326665 |
| 134 | MAP2K6 | 0.30831628 |
| 135 | PRKDC | 0.30495925 |
| 136 | TAOK1 | 0.29942941 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 5.77338269 |
| 2 | Protein export_Homo sapiens_hsa03060 | 3.35101521 |
| 3 | Insulin secretion_Homo sapiens_hsa04911 | 3.25123803 |
| 4 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.90370182 |
| 5 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.78827014 |
| 6 | Phototransduction_Homo sapiens_hsa04744 | 2.47398143 |
| 7 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 2.39781594 |
| 8 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 2.25486799 |
| 9 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.14698717 |
| 10 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.11908058 |
| 11 | Cocaine addiction_Homo sapiens_hsa05030 | 2.06106121 |
| 12 | Parkinsons disease_Homo sapiens_hsa05012 | 2.01886490 |
| 13 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.00165116 |
| 14 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.99766634 |
| 15 | * GABAergic synapse_Homo sapiens_hsa04727 | 1.95681054 |
| 16 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.91241403 |
| 17 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.90019696 |
| 18 | Long-term potentiation_Homo sapiens_hsa04720 | 1.88992959 |
| 19 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.84718215 |
| 20 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.82694478 |
| 21 | * Circadian entrainment_Homo sapiens_hsa04713 | 1.78825054 |
| 22 | Taste transduction_Homo sapiens_hsa04742 | 1.78435275 |
| 23 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.78204686 |
| 24 | Nicotine addiction_Homo sapiens_hsa05033 | 1.76023469 |
| 25 | * Dopaminergic synapse_Homo sapiens_hsa04728 | 1.73862325 |
| 26 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.67317343 |
| 27 | * Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.58878166 |
| 28 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.55264376 |
| 29 | * Morphine addiction_Homo sapiens_hsa05032 | 1.50630556 |
| 30 | * Cholinergic synapse_Homo sapiens_hsa04725 | 1.50389961 |
| 31 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.48853940 |
| 32 | Olfactory transduction_Homo sapiens_hsa04740 | 1.47274396 |
| 33 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.44323979 |
| 34 | * Serotonergic synapse_Homo sapiens_hsa04726 | 1.36680471 |
| 35 | * Glutamatergic synapse_Homo sapiens_hsa04724 | 1.33283285 |
| 36 | Huntingtons disease_Homo sapiens_hsa05016 | 1.30180970 |
| 37 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.25356214 |
| 38 | RNA polymerase_Homo sapiens_hsa03020 | 1.19913736 |
| 39 | Renin secretion_Homo sapiens_hsa04924 | 1.15595694 |
| 40 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.14462108 |
| 41 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.12186845 |
| 42 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.11422082 |
| 43 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.11160983 |
| 44 | Long-term depression_Homo sapiens_hsa04730 | 1.10619743 |
| 45 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.09891847 |
| 46 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.09749446 |
| 47 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.08308767 |
| 48 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.07923900 |
| 49 | Salivary secretion_Homo sapiens_hsa04970 | 1.07032679 |
| 50 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.03766874 |
| 51 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 1.03533631 |
| 52 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.02132475 |
| 53 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.01542865 |
| 54 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.00811909 |
| 55 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.00282490 |
| 56 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.98851549 |
| 57 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.98709957 |
| 58 | Basal transcription factors_Homo sapiens_hsa03022 | 0.97998588 |
| 59 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.96293726 |
| 60 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.94770839 |
| 61 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.93486775 |
| 62 | Lysosome_Homo sapiens_hsa04142 | 0.91905630 |
| 63 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.90159354 |
| 64 | Peroxisome_Homo sapiens_hsa04146 | 0.87090416 |
| 65 | Prion diseases_Homo sapiens_hsa05020 | 0.87011300 |
| 66 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.86820824 |
| 67 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.86050401 |
| 68 | Gap junction_Homo sapiens_hsa04540 | 0.85408323 |
| 69 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.84485231 |
| 70 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.84323697 |
| 71 | Circadian rhythm_Homo sapiens_hsa04710 | 0.82669888 |
| 72 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.82449323 |
| 73 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.80243928 |
| 74 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.80064562 |
| 75 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.79984168 |
| 76 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.77480787 |
| 77 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.77269046 |
| 78 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.77167992 |
| 79 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.76733858 |
| 80 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.74671021 |
| 81 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.73694576 |
| 82 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.73003549 |
| 83 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.72334282 |
| 84 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.72331789 |
| 85 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.71431026 |
| 86 | Glioma_Homo sapiens_hsa05214 | 0.70919726 |
| 87 | RNA degradation_Homo sapiens_hsa03018 | 0.70517914 |
| 88 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.69566572 |
| 89 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.67000457 |
| 90 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.66573612 |
| 91 | Melanogenesis_Homo sapiens_hsa04916 | 0.65319605 |
| 92 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.65248733 |
| 93 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.64765951 |
| 94 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.64256619 |
| 95 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.64047652 |
| 96 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.63911262 |
| 97 | Insulin resistance_Homo sapiens_hsa04931 | 0.63805964 |
| 98 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.63503852 |
| 99 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.63201571 |
| 100 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.61892734 |
| 101 | * Alcoholism_Homo sapiens_hsa05034 | 0.61368083 |
| 102 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.60241310 |
| 103 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.58367321 |
| 104 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.57660908 |
| 105 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.56588067 |
| 106 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.56449529 |
| 107 | Endometrial cancer_Homo sapiens_hsa05213 | 0.54458219 |
| 108 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.53751599 |
| 109 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.50999276 |
| 110 | Metabolic pathways_Homo sapiens_hsa01100 | 0.50827840 |
| 111 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.49474325 |
| 112 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.48872745 |
| 113 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.46548403 |
| 114 | Phagosome_Homo sapiens_hsa04145 | 0.45959007 |
| 115 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.44929217 |
| 116 | Axon guidance_Homo sapiens_hsa04360 | 0.44463373 |
| 117 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.44418589 |
| 118 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.43554246 |
| 119 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.42929047 |
| 120 | Purine metabolism_Homo sapiens_hsa00230 | 0.42008997 |
| 121 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.41785694 |
| 122 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.39427659 |
| 123 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.39384458 |
| 124 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.38694672 |
| 125 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.38579501 |
| 126 | ABC transporters_Homo sapiens_hsa02010 | 0.38379692 |
| 127 | Galactose metabolism_Homo sapiens_hsa00052 | 0.37836622 |
| 128 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.37796128 |
| 129 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.37533877 |
| 130 | Alzheimers disease_Homo sapiens_hsa05010 | 0.37514832 |
| 131 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.36566761 |
| 132 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.35611494 |
| 133 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.35001158 |
| 134 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.34931696 |
| 135 | Retinol metabolism_Homo sapiens_hsa00830 | 0.34818364 |
| 136 | Endocytosis_Homo sapiens_hsa04144 | 0.34728281 |
| 137 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.34581710 |
| 138 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.33894148 |
| 139 | Bile secretion_Homo sapiens_hsa04976 | 0.32599220 |
| 140 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.32561757 |
| 141 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.32033559 |
| 142 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.31372958 |
| 143 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.31154799 |
| 144 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.30378314 |
| 145 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.29747787 |
| 146 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.29579460 |
| 147 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.29043581 |
| 148 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.28551913 |
| 149 | Other glycan degradation_Homo sapiens_hsa00511 | 0.27206724 |
| 150 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.27189486 |
| 151 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.27170175 |

